Fuse Medical, Inc.
FZMD
$0.062
-$0.0279-31.03%
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 18.40M | 18.08M | 18.64M | 19.82M | 19.53M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.40M | 18.08M | 18.64M | 19.82M | 19.53M |
| Cost of Revenue | 6.45M | 6.95M | 7.53M | 7.80M | 8.18M |
| Gross Profit | 11.95M | 11.12M | 11.12M | 12.02M | 11.35M |
| SG&A Expenses | 12.13M | 11.95M | 12.22M | 13.18M | 13.31M |
| Depreciation & Amortization | 59.50K | 61.20K | 62.20K | 171.90K | 104.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.64M | 18.96M | 19.81M | 21.15M | 21.59M |
| Operating Income | -239.70K | -889.80K | -1.16M | -1.33M | -2.06M |
| Income Before Tax | 3.66M | 3.02M | 2.77M | -1.14M | -1.83M |
| Income Tax Expenses | 26.50K | 24.50K | 23.80K | 22.40K | 18.60K |
| Earnings from Continuing Operations | 3.63 | 3.00 | 2.75 | -1.16 | -1.85 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.63M | 3.00M | 2.75M | -1.16M | -1.85M |
| EBIT | -239.70K | -889.80K | -1.16M | -1.33M | -2.06M |
| EBITDA | -57.00K | -705.40K | -977.40K | -1.16M | -1.96M |
| EPS Basic | 0.05 | 0.04 | 0.04 | -0.02 | -0.03 |
| Normalized Basic EPS | 0.00 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted | 0.04 | 0.03 | 0.02 | -0.02 | -0.03 |
| Normalized Diluted EPS | 0.00 | -0.01 | -0.01 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 281.29M | 281.29M | 281.29M | 281.59M | 281.49M |
| Average Diluted Shares Outstanding | 319.15M | 311.44M | 311.44M | 281.59M | 281.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
